| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:42 UTC |
|---|
| HMDB ID | HMDB0014699 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Bosentan |
|---|
| Description | Bosentan, also known as tracleer or bosentan hydrate, belongs to the class of organic compounds known as bipyrimidines and oligopyrimidines. These are organic compounds containing two or more pyrimidine rings directly linked to each other. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Bosentan is a drug which is used in the treatment of pulmonary arterial hypertension (pah), to improve exercise ability and to decrease the rate of clinical worsening (in patients with who class iii or iv symptoms). Bosentan was studied in heart failure in a trial called REACH-1 that was terminated early in 1997 due to toxicity at the dose that was being studied; as of 2001 the results of that trial had not been published. Bosentan is an extremely weak basic (essentially neutral) compound (based on its pKa). The doctor must document a negative pregnancy test for women before prescribing the drug, counsel about contraception, and give regular pregnancy tests. Under normal conditions, endothelin-1 binding of ET-A receptors causes constriction of the pulmonary blood vessels. Peak plasma concentration of bosentan with the dispersable tablets for oral suspension is 14% less on average compared to peak concentration of the oral tablets. |
|---|
| Structure | COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1 InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide | ChEBI | | Bosentanum | ChEBI | | p-Tert-butyl-N-(6-(2-hydroxyethoxy)-5-(O-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide | ChEBI | | 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulphornamide | Generator | | p-Tert-butyl-N-(6-(2-hydroxyethoxy)-5-(O-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulphonamide | Generator | | Bosentan hydrate | HMDB | | 4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide | HMDB | | Bosentan monohydrate | HMDB | | Bosentan anhydrous | HMDB | | Tracleer | HMDB |
|
|---|
| Chemical Formula | C27H29N5O6S |
|---|
| Average Molecular Weight | 551.614 |
|---|
| Monoisotopic Molecular Weight | 551.183854375 |
|---|
| IUPAC Name | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide |
|---|
| Traditional Name | bosentan |
|---|
| CAS Registry Number | 147536-97-8 |
|---|
| SMILES | COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1 |
|---|
| InChI Identifier | InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32) |
|---|
| InChI Key | GJPICJJJRGTNOD-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as bipyrimidines and oligopyrimidines. These are organic compounds containing two or more pyrimidine rings directly linked to each other. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyrimidines and pyrimidine derivatives |
|---|
| Direct Parent | Bipyrimidines and oligopyrimidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Bipyrimidine
- Diaryl ether
- Benzenesulfonamide
- Benzenesulfonyl group
- Phenylpropane
- Phenoxy compound
- Anisole
- Phenol ether
- Methoxybenzene
- Alkyl aryl ether
- Monocyclic benzene moiety
- Imidolactam
- Benzenoid
- Organosulfonic acid amide
- Heteroaromatic compound
- Aminosulfonyl compound
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Azacycle
- Ether
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Primary alcohol
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.009 g/L | Not Available | | LogP | 3.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.89 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.5539 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.36 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 33.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3340.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 169.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 192.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 152.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 141.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 633.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 737.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 79.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1139.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 573.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1350.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 333.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 418.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 108.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 125.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Bosentan,1TMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4289.5 | Semi standard non polar | 33892256 | | Bosentan,1TMS,isomer #2 | COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4149.8 | Semi standard non polar | 33892256 | | Bosentan,2TMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4165.7 | Semi standard non polar | 33892256 | | Bosentan,2TMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4135.6 | Standard non polar | 33892256 | | Bosentan,2TMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 5766.8 | Standard polar | 33892256 | | Bosentan,1TBDMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C(C)(C)C)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4473.1 | Semi standard non polar | 33892256 | | Bosentan,1TBDMS,isomer #2 | COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4349.4 | Semi standard non polar | 33892256 | | Bosentan,2TBDMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C(C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4508.3 | Semi standard non polar | 33892256 | | Bosentan,2TBDMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C(C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 4552.1 | Standard non polar | 33892256 | | Bosentan,2TBDMS,isomer #1 | COC1=CC=CC=C1OC1=C(OCCO[Si](C)(C)C(C)(C)C)N=C(C2=NC=CC=N2)N=C1N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 | 5746.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS (Non-derivatized) - 70eV, Positive | splash10-0k9f-1404490000-6d317563fca85570bb94 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS (1 TMS) - 70eV, Positive | splash10-0ab9-8400329000-23bc8d319fee004b04e7 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS ("Bosentan,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Bosentan GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan LC-ESI-QFT , negative-QTOF | splash10-0udj-0810090000-b97444dff91ec725276d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan LC-ESI-QFT , positive-QTOF | splash10-0udi-1690040000-c561d9dbb5ed88285519 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 50V, Positive-QTOF | splash10-0udi-0290000000-917fcf22a5648855f494 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 20V, Positive-QTOF | splash10-0udi-0000090000-804fbcd24b248dea41cb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 10V, Positive-QTOF | splash10-0udi-0000090000-37d3e81ca9fac1bb8607 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 30V, Positive-QTOF | splash10-0udi-0032090000-6b8d5527e6d09bf8bd93 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 40V, Positive-QTOF | splash10-0udi-0192000000-ac3f1b4e6b6da63962f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 35V, Positive-QTOF | splash10-0udi-1690040000-53b916bf54d069a5d9af | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bosentan 35V, Negative-QTOF | splash10-0udj-0700090000-a1325fb53ae46b3119a0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 10V, Positive-QTOF | splash10-0udi-0020190000-45fdf2d2b678882a2c9a | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 20V, Positive-QTOF | splash10-01r2-7853970000-73d404cdce8bec564973 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 40V, Positive-QTOF | splash10-0zmr-4911000000-355d0a86f2c020114251 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 10V, Negative-QTOF | splash10-0udi-1111090000-838b3a76b34448d48154 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 20V, Negative-QTOF | splash10-00b9-1938000000-4a504df1e7892ab5ed7b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 40V, Negative-QTOF | splash10-03g3-8592000000-757b42467cf720e1d98b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 10V, Positive-QTOF | splash10-0udi-0000090000-0264cc47a8b7eb39ffb5 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 20V, Positive-QTOF | splash10-0pb9-0200190000-c06202aa662980be16e4 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 40V, Positive-QTOF | splash10-0ab9-6900720000-9771730325d97d3f1f0f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 10V, Negative-QTOF | splash10-0udi-0000090000-12b263be07bc58a79d77 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 20V, Negative-QTOF | splash10-0zfu-0101490000-41d3bf6ec3c473268216 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bosentan 40V, Negative-QTOF | splash10-0udj-0223930000-515898571490d1845bf8 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|